These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23630964)

  • 21. Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms.
    Streit JA; Recker TJ; Filho FG; Beverley SM; Wilson ME
    J Immunol; 2001 Feb; 166(3):1921-9. PubMed ID: 11160240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations on the in vitro metacyclogenesis of a visceral and a cutaneous human strain of Leishmania infantum.
    Louassini M; Adroher FJ; Foulquié MR; Benítez R
    Acta Trop; 1998 Jul; 70(3):355-68. PubMed ID: 9777720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stage-specific adhesion of Leishmania promastigotes to sand fly midguts assessed using an improved comparative binding assay.
    Wilson R; Bates MD; Dostalova A; Jecna L; Dillon RJ; Volf P; Bates PA
    PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20838647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the composition of the plasma membrane of Leishmania (Leishmania) infantum and L. (L.) amazonensis using label-free proteomics.
    Oliveira IHR; Figueiredo HCP; Rezende CP; Verano-Braga T; Melo-Braga MN; Reis Cunha JL; de Andrade HM
    Exp Parasitol; 2020 Nov; 218():107964. PubMed ID: 32822697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of infectivity caused by promastigotes of Leishmania infantum MON-1, L. infantum MON-24 and L. donovani MON-18.
    Santos-Gomes GM; Abranches P
    Folia Parasitol (Praha); 1996; 43(1):7-12. PubMed ID: 8682411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmania infantum ecto-nucleoside triphosphate diphosphohydrolase-2 is an apyrase involved in macrophage infection and expressed in infected dogs.
    Vasconcellos Rde S; Mariotini-Moura C; Gomes RS; Serafim TD; Firmino Rde C; Silva E Bastos M; Castro FF; Oliveira CM; Borges-Pereira L; de Souza AC; de Souza RF; Gómez GA; Pinheiro Ada C; Maciel TE; Silva-Júnior A; Bressan GC; Almeida MR; Baqui MM; Afonso LC; Fietto JL
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3309. PubMed ID: 25393008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic analysis of exosomes derived from procyclic and metacyclic-like cultured Leishmania infantum chagasi.
    Forrest DM; Batista M; Marchini FK; Tempone AJ; Traub-Csekö YM
    J Proteomics; 2020 Sep; 227():103902. PubMed ID: 32673755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lectin pathway of complement and the initial recognition of Leishmania infantum promastigotes.
    Ambrosio AR; Bavia L; Hiraiwa PM; Tirado TC; Figueiredo FB; de Messias-Reason IJ
    Life Sci; 2021 Oct; 282():119793. PubMed ID: 34242658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Miltefosine enhances the fitness of a non-virulent drug-resistant Leishmania infantum strain.
    Eberhardt E; Bulté D; Van Bockstal L; Van den Kerkhof M; Cos P; Delputte P; Hendrickx S; Maes L; Caljon G
    J Antimicrob Chemother; 2019 Feb; 74(2):395-406. PubMed ID: 30412253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmania infantum proteophosphoglycans regurgitated by the bite of its natural sand fly vector, Lutzomyia longipalpis, promote parasite establishment in mouse skin and skin-distant tissues.
    Rogers ME; Corware K; Müller I; Bates PA
    Microbes Infect; 2010 Oct; 12(11):875-9. PubMed ID: 20561596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.
    Freitas EO; Nico D; Guan R; Meyer-Fernandes JR; Clinch K; Evans GB; Tyler PC; Schramm VL; Palatnik-de-Sousa CB
    PLoS One; 2015; 10(4):e0124183. PubMed ID: 25909893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmania infantum transfected with toxic plasmid induces protection in mice infected with wild type L. infantum or L. amazonensis.
    Zorgi NE; Arruda LV; Paladine I; Roque GAS; Araújo TF; Brocchi M; Barral M; Sanchiz Á; Requena JM; Abánades DR; Giorgio S
    Mol Immunol; 2020 Nov; 127():95-106. PubMed ID: 32949849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of distinct culture media in Leishmania infantum biology and infectivity.
    Santarém N; Cunha J; Silvestre R; Silva C; Moreira D; Ouellette M; Cordeiro-DA-Silva A
    Parasitology; 2014 Feb; 141(2):192-205. PubMed ID: 24007671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leishmania infantum-chagasi activates SHP-1 and reduces NFAT5/TonEBP activity in the mouse kidney inner medulla.
    Zhou X; Wang H; Koles NL; Zhang A; Aronson NE
    Am J Physiol Renal Physiol; 2014 Sep; 307(5):F516-24. PubMed ID: 24990897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Leishmania infantum chagasi proteins in urine of patients with visceral leishmaniasis: a promising antigen discovery approach of vaccine candidates.
    Kashino SS; Abeijon C; Qin L; Kanunfre KA; Kubrusly FS; Silva FO; Costa DL; Campos D; Costa CH; Raw I; Campos-Neto A
    Parasite Immunol; 2012 Jul; 34(7):360-71. PubMed ID: 22443237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum.
    González P; Marín C; Rodríguez-González I; Hitos AB; Rosales MJ; Reina M; Díaz JG; González-Coloma A; Sánchez-Moreno M
    Int J Antimicrob Agents; 2005 Feb; 25(2):136-41. PubMed ID: 15664483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of prostaglandin F2α production in lipid bodies from Leishmania infantum chagasi: insights on virulence.
    Araújo-Santos T; Rodríguez NE; Moura-Pontes S; Dixt UG; Abánades DR; Bozza PT; Wilson ME; Borges VM
    J Infect Dis; 2014 Dec; 210(12):1951-61. PubMed ID: 24850789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.